BioCentury
ARTICLE | Emerging Company Profile

Blackfield: Mining cancer genomes

Blackfield offering cancer genomics-based drug discovery services

March 11, 2013 7:00 AM UTC

Blackfield AG is leveraging the genome analysis experience and oncology expertise of its academic founders to offer a one-stop shop for cancer genomics-based drug discovery services.

The University of Cologne spinout was founded last year to commercialize work from the lab of Roman Thomas, chair of the department of translational genomics and Blackfield's scientific director...